I. Yonal-Hindilerden Et Al. , "The Clinical Impact of the Burden of JAK2V617F Mutated Allele in Philadelphia-Negative Chronic Myeloproliferative Neoplasms," CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.20, 2020
Yonal-Hindilerden, I. Et Al. 2020. The Clinical Impact of the Burden of JAK2V617F Mutated Allele in Philadelphia-Negative Chronic Myeloproliferative Neoplasms. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.20 .
Yonal-Hindilerden, I., Sahin, E., Hindilerden, F., Daglar-Aday, A., & Nalcaci, M., (2020). The Clinical Impact of the Burden of JAK2V617F Mutated Allele in Philadelphia-Negative Chronic Myeloproliferative Neoplasms. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.20.
Yonal-Hindilerden, İpek Et Al. "The Clinical Impact of the Burden of JAK2V617F Mutated Allele in Philadelphia-Negative Chronic Myeloproliferative Neoplasms," CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.20, 2020
Yonal-Hindilerden, İpek Y. Et Al. "The Clinical Impact of the Burden of JAK2V617F Mutated Allele in Philadelphia-Negative Chronic Myeloproliferative Neoplasms." CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.20, 2020
Yonal-Hindilerden, I. Et Al. (2020) . "The Clinical Impact of the Burden of JAK2V617F Mutated Allele in Philadelphia-Negative Chronic Myeloproliferative Neoplasms." CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.20.
@article{article, author={İpek YÖNAL HİNDİLERDEN Et Al. }, title={The Clinical Impact of the Burden of JAK2V617F Mutated Allele in Philadelphia-Negative Chronic Myeloproliferative Neoplasms}, journal={CLINICAL LYMPHOMA MYELOMA & LEUKEMIA}, year=2020}